205 related articles for article (PubMed ID: 24119443)
1. Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.
Kjersem JB; Ikdahl T; Lingjaerde OC; Guren T; Tveit KM; Kure EH
Mol Oncol; 2014 Feb; 8(1):59-67. PubMed ID: 24119443
[TBL] [Abstract][Full Text] [Related]
2. Exploring microRNA patterns as biomarkers of FOLFOX chemotherapy-induced peripheral neuropathy in patients with colorectal cancer.
Ju Y; Baek DH; Choi GE; Jang A
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167209. PubMed ID: 38701955
[TBL] [Abstract][Full Text] [Related]
3. Expression of Topoisomerase 1 and carboxylesterase 2 correlates with irinotecan treatment response in metastatic colorectal cancer.
Shaojun C; Li H; Haixin H; Guisheng L
Cancer Biol Ther; 2018 Mar; 19(3):153-159. PubMed ID: 29261002
[TBL] [Abstract][Full Text] [Related]
4. Modulators of the Nrf2 Signaling Pathway Enhance the Cytotoxic Effect of Standard Chemotherapeutic Drugs on Organoids of Metastatic Colorectal Cancer.
Razumovskaya AV; Silkina MO; Nikulin SV; Tonevitsky AG; Alekseev BY
Bull Exp Biol Med; 2024 Mar; 176(5):703-708. PubMed ID: 38724815
[TBL] [Abstract][Full Text] [Related]
5. Treatment considerations in elderly colorectal cancer patients.
McCleary NJ
Clin Adv Hematol Oncol; 2010 May; 8(5):337-9. PubMed ID: 20551893
[No Abstract] [Full Text] [Related]
6. Genome-wide identification of chemosensitive single nucleotide polymorphism markers in colorectal cancers.
Kim JC; Kim SY; Cho DH; Roh SA; Choi EY; Jo YK; Jung SH; Na YS; Kim TW; Kim YS
Cancer Sci; 2010 Apr; 101(4):1007-13. PubMed ID: 20085586
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating microRNAs with Ago2 complexes to monitor the tumor dynamics of colorectal cancer patients during chemotherapy.
Fuji T; Umeda Y; Nyuya A; Taniguchi F; Kawai T; Yasui K; Toshima T; Yoshida K; Fujiwara T; Goel A; Nagasaka T
Int J Cancer; 2019 May; 144(9):2169-2180. PubMed ID: 30381824
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases.
Oshima G; Guo N; He C; Stack ME; Poon C; Uppal A; Wightman SC; Parekh A; Skowron KB; Posner MC; Lin W; Khodarev NN; Weichselbaum RR
Mol Ther; 2017 Jul; 25(7):1588-1595. PubMed ID: 28457664
[TBL] [Abstract][Full Text] [Related]
9. Metastatic colorectal cancer-past, progress and future.
Field K; Lipton L
World J Gastroenterol; 2007 Jul; 13(28):3806-15. PubMed ID: 17657834
[TBL] [Abstract][Full Text] [Related]
10. Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer.
Hansen TF; Carlsen AL; Heegaard NH; Sørensen FB; Jakobsen A
Br J Cancer; 2015 Feb; 112(4):624-9. PubMed ID: 25584492
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy.
Zhang J; Zhang K; Bi M; Jiao X; Zhang D; Dong Q
Anticancer Drugs; 2014 Mar; 25(3):346-52. PubMed ID: 24304648
[TBL] [Abstract][Full Text] [Related]
12. Circulating exosomal microRNAs as biomarkers of colon cancer.
Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
[TBL] [Abstract][Full Text] [Related]
13. Predicting distant metastasis and chemoresistance using plasma miRNAs.
Chen J; Wang W; Zhang Y; Chen Y; Hu T
Med Oncol; 2014 Jan; 31(1):799. PubMed ID: 24310813
[TBL] [Abstract][Full Text] [Related]
14. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
[TBL] [Abstract][Full Text] [Related]
16. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression.
Aherne ST; Madden SF; Hughes DJ; Pardini B; Naccarati A; Levy M; Vodicka P; Neary P; Dowling P; Clynes M
BMC Cancer; 2015 Apr; 15():329. PubMed ID: 25924769
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients.
Summerer I; Niyazi M; Unger K; Pitea A; Zangen V; Hess J; Atkinson MJ; Belka C; Moertl S; Zitzelsberger H
Radiat Oncol; 2015 Apr; 10():102. PubMed ID: 25903761
[No Abstract] [Full Text] [Related]
18. Differential expression of circulating microRNAs according to severity of colorectal neoplasia.
Ho GYF; Jung HJ; Schoen RE; Wang T; Lin J; Williams Z; Weissfeld JL; Park JY; Loudig O; Suh Y
Transl Res; 2015 Sep; 166(3):225-232. PubMed ID: 25770825
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer.
Nonaka R; Nishimura J; Kagawa Y; Osawa H; Hasegawa J; Murata K; Okamura S; Ota H; Uemura M; Hata T; Takemasa I; Mizushima T; Okuzaki D; Yamamoto H; Doki Y; Mori M
Oncol Rep; 2014 Dec; 32(6):2354-8. PubMed ID: 25269744
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer.
Wang J; Raimondo M; Guha S; Chen J; Diao L; Dong X; Wallace MB; Killary AM; Frazier ML; Woodward TA; Wang J; Sen S
J Cancer; 2014; 5(8):696-705. PubMed ID: 25258651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
